SPONSOR
Jazz Pharmaceuticals
Total Trials
3
Recruiting
3
Phases
Phase 1, Phase 2
Conditions studied: Central Nervous System NeoplasmsGlioblastomaGliosarcoma, AdultAnaplastic OligodendrogliomaAnaplastic AstrocytomaPilocytic AstrocytomaOligodendrogliomaGliomatosis CerebriPleomorphic XanthoastrocytomaAnaplastic Pleomorphic Xanthoastrocytoma
Jazz Pharmaceuticals is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Central Nervous System Neoplasms, Glioblastoma, Gliosarcoma, Adult, Anaplastic Oligodendroglioma.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Jazz Pharmaceuticals
How many clinical trials has Jazz Pharmaceuticals sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Jazz Pharmaceuticals, of which 3 are actively recruiting participants. These trials cover conditions including Central Nervous System Neoplasms, Glioblastoma, Gliosarcoma, Adult. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Jazz Pharmaceuticals research focus on?
Jazz Pharmaceuticals clinical trials span Central Nervous System Neoplasms, Glioblastoma, Gliosarcoma, Adult, Anaplastic Oligodendroglioma, Anaplastic Astrocytoma, and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Jazz Pharmaceuticals clinical trial?
To participate in a Jazz Pharmaceuticals trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Jazz Pharmaceuticals trials with current recruitment status updated daily.
Clinical Trials by Jazz Pharmaceuticals
NCT04541082 Phase 1
Recruiting
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Central Nervous System Neoplasms
NCT06108050 Phase 1
Recruiting
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
Advanced Solid Tumor
NCT07102381 Phase 2
Recruiting
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
HER2-positive Breast Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology